The Molecular Virology and Reverse Genetics of Influenza C Virus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones
Direct Agroinoculation of Maize Seedlings by Injection with Recombinant Foxtail Mosaic Virus and Sugarcane Mosaic Virus Infectious Clones Bliss M. Beernink*,1, Katerina L. Holan*,1, Ryan R. Lappe1, Steven A. Whitham1 1 Department of Plant Pathology and Microbiology, Iowa State University * These authors contributed equally Corresponding Author Abstract Steven A. Whitham [email protected] Agrobacterium-based inoculation approaches are widely used for introducing viral vectors into plant tissues. This study details a protocol for the injection of maize Citation seedlings near meristematic tissue with Agrobacterium carrying a viral vector. Beernink, B.M., Holan, K.L., Lappe, R.R., Recombinant foxtail mosaic virus (FoMV) clones engineered for gene silencing and Whitham, S.A. Direct Agroinoculation of Maize Seedlings by Injection with gene expression were used to optimize this method, and its use was expanded Recombinant Foxtail Mosaic Virus and to include a recombinant sugarcane mosaic virus (SCMV) engineered for gene Sugarcane Mosaic Virus Infectious Clones. J. Vis. Exp. (168), e62277, expression. Gene fragments or coding sequences of interest are inserted into a doi:10.3791/62277 (2021). modified, infectious viral genome that has been cloned into the binary T-DNA plasmid vector pCAMBIA1380. The resulting plasmid constructs are transformed into Date Published Agrobacterium tumefaciens strain GV3101. Maize seedlings as young as 4 days February 27, 2021 old can be injected near the coleoptilar node with bacteria resuspended in MgSO4 DOI -
Influenza Virus Infections in Humans October 2018
Influenza virus infections in humans October 2018 This note is provided in order to clarify the differences among seasonal influenza, pandemic influenza, and zoonotic or variant influenza. Seasonal influenza Seasonal influenza viruses circulate and cause disease in humans every year. In temperate climates, disease tends to occur seasonally in the winter months, spreading from person-to- person through sneezing, coughing, or touching contaminated surfaces. Seasonal influenza viruses can cause mild to severe illness and even death, particularly in some high-risk individuals. Persons at increased risk for severe disease include pregnant women, the very young and very old, immune-compromised people, and people with chronic underlying medical conditions. Seasonal influenza viruses evolve continuously, which means that people can get infected multiple times throughout their lives. Therefore the components of seasonal influenza vaccines are reviewed frequently (currently biannually) and updated periodically to ensure continued effectiveness of the vaccines. There are three large groupings or types of seasonal influenza viruses, labeled A, B, and C. Type A influenza viruses are further divided into subtypes according to the specific variety and combinations of two proteins that occur on the surface of the virus, the hemagglutinin or “H” protein and the neuraminidase or “N” protein. Currently, influenza A(H1N1) and A(H3N2) are the circulating seasonal influenza A virus subtypes. This seasonal A(H1N1) virus is the same virus that caused the 2009 influenza pandemic, as it is now circulating seasonally. In addition, there are two type B viruses that are also circulating as seasonal influenza viruses, which are named after the areas where they were first identified, Victoria lineage and Yamagata lineage. -
Use of Cell Culture in Virology for Developing Countries in the South-East Asia Region © World Health Organization 2017
USE OF CELL C USE OF CELL U LT U RE IN VIROLOGY FOR DE RE IN VIROLOGY V ELOPING C O U NTRIES IN THE NTRIES IN S O U TH- E AST USE OF CELL CULTURE A SIA IN VIROLOGY FOR R EGION ISBN: 978-92-9022-600-0 DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION World Health House Indraprastha Estate, Mahatma Gandhi Marg, New Delhi-110002, India Website: www.searo.who.int USE OF CELL CULTURE IN VIROLOGY FOR DEVELOPING COUNTRIES IN THE SOUTH-EAST ASIA REGION © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition.” Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. -
Chapter 14: Functional Genomics Learning Objectives
Chapter 14: Functional Genomics Learning objectives Upon reading this chapter, you should be able to: ■ define functional genomics; ■ describe the key features of eight model organisms; ■ explain techniques of forward and reverse genetics; ■ discuss the relation between the central dogma and functional genomics; and ■ describe proteomics-based approaches to functional genomics. Outline : Functional genomics Introduction Relation between genotype and phenotype Eight model organisms E. coli; yeast; Arabidopsis; C. elegans; Drosophila; zebrafish; mouse; human Functional genomics using reverse and forward genetics Reverse genetics: mouse knockouts; yeast; gene trapping; insertional mutatgenesis; gene silencing Forward genetics: chemical mutagenesis Functional genomics and the central dogma Approaches to function; Functional genomics and DNA; …and RNA; …and protein Proteomic approaches to functional genomics CASP; protein-protein interactions; protein networks Perspective Albert Blakeslee (1874–1954) studied the effect of altered chromosome numbers on the phenotype of the jimson-weed Datura stramonium, a flowering plant. Introduction: Functional genomics Functional genomics is the genome-wide study of the function of DNA (including both genes and non-genic regions), as well as RNA and proteins encoded by DNA. The term “functional genomics” may apply to • the genome, transcriptome, or proteome • the use of high-throughput screens • the perturbation of gene function • the complex relationship of genotype and phenotype Functional genomics approaches to high throughput analyses Relationship between genotype and phenotype The genotype of an individual consists of the DNA that comprises the organism. The phenotype is the outward manifestation in terms of properties such as size, shape, movement, and physiology. We can consider the phenotype of a cell (e.g., a precursor cell may develop into a brain cell or liver cell) or the phenotype of an organism (e.g., a person may have a disease phenotype such as sickle‐cell anemia). -
Epidemiology and Clinical Characteristics of Influenza C Virus
viruses Review Epidemiology and Clinical Characteristics of Influenza C Virus Bethany K. Sederdahl 1 and John V. Williams 1,2,* 1 Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA; [email protected] 2 Institute for Infection, Inflammation, and Immunity in Children (i4Kids), University of Pittsburgh, Pittsburgh, PA 15224, USA * Correspondence: [email protected] Received: 30 December 2019; Accepted: 7 January 2020; Published: 13 January 2020 Abstract: Influenza C virus (ICV) is a common yet under-recognized cause of acute respiratory illness. ICV seropositivity has been found to be as high as 90% by 7–10 years of age, suggesting that most people are exposed to ICV at least once during childhood. Due to difficulty detecting ICV by cell culture, epidemiologic studies of ICV likely have underestimated the burden of ICV infection and disease. Recent development of highly sensitive RT-PCR has facilitated epidemiologic studies that provide further insights into the prevalence, seasonality, and course of ICV infection. In this review, we summarize the epidemiology and clinical characteristics of ICV. Keywords: orthomyxoviruses; influenza C; epidemiology 1. Introduction Influenza C virus (ICV) is lesser known type of influenza virus that commonly causes cold-like symptoms and sometimes causes lower respiratory infection, especially in children <2 years of age [1]. ICV is mainly a human pathogen; however, the virus has been detected in pigs, dogs, and cattle, and rare swine–human transmission has been reported [2–6]. ICV seropositivity has been found to be as high as 90% by 7–10 years of age, suggesting that most people are exposed to influenza C virus at least once during childhood [7,8]. -
Isolation of Influenza C Virus During the 1 999/2000 - Influenza Season in Hiroshima Prefecture, Japan
Jpn. J. Infect. Dis., 53, 2000 Laboratory and Epidemiology Communications Isolation of Influenza C Virus during the 1 999/2000 - Influenza Season in Hiroshima Prefecture, Japan Shinichi Takao*, Yoko MatsuzakiI , Yukie Shimazu, Shinji Fukuda, Masahiro Noda and Shizuyo Tbkumoto Division of Microbiology II, Hiroshima Prefectural Institute of Health and EnviylDnment, Minami-machi Il6-29, Minami-ku, Hiroshima 734-0007 and JDepartment ofBacleriology, Yamagata UniversiOJ School of Medicine, Iida-Nishi 2-2-2, Yamagata 990-9585 Communicated by Hiroo lnouye (Accepted August 16, 2000) Althoughinfluenza C virus is considered to be an etiological Vimses were isolated by uslng MDCK cells andノor 7-day- agent formi1d upper respiratory illness in humans (1), it ca.n old embryonated hen's eggs (Table). In MDCK cells, the also?ause lower resplratOry tract infection (2)・ Seroepidem1- viruses produced only weak cytopathic effects sand grew very 010glCal studies have revealed that the virus is prevalent slowly. Several passages were necessary to attain a hemag- worldwide and that infection occurs at an early stage in life (3,4)・ Howe.ver・ there is little information regarding its epidemiologlCal and clinical features because the virus has only occasionally been isolated (2,5,6). According to the Infectious Agents Surveillance Report in Japan, while 5,699 innueTza A(HIN 1 )virus isolates, 12,822 innuenzaA(H3N2) virus isolates and 5,232 influenza B virus isolates were reported in 1991-1996 in Japan, only 18 isolates ofinnuenza C virus were reported during the same period (7). In this paper, We report eight isolated cases of influenza C virus from the 1 999/2000 - influenza season in Hiroshima Prefecture, Japan. -
Recombinant and Chimeric Viruses
Recombinant and chimeric viruses: Evaluation of risks associated with changes in tropism Ben P.H. Peeters Animal Sciences Group, Wageningen University and Research Centre, Division of Infectious Diseases, P.O. Box 65, 8200 AB Lelystad, The Netherlands. May 2005 This report represents the personal opinion of the author. The interpretation of the data presented in this report is the sole responsibility of the author and does not necessarily represent the opinion of COGEM or the Animal Sciences Group. Dit rapport is op persoonlijke titel door de auteur samengesteld. De interpretatie van de gepresenteerde gegevens komt geheel voor rekening van de auteur en representeert niet de mening van de COGEM, noch die van de Animal Sciences Group. Advisory Committee Prof. dr. R.C. Hoeben (Chairman) Leiden University Medical Centre Dr. D. van Zaane Wageningen University and Research Centre Dr. C. van Maanen Animal Health Service Drs. D. Louz Bureau Genetically Modified Organisms Ing. A.M.P van Beurden Commission on Genetic Modification Recombinant and chimeric viruses 2 INHOUDSOPGAVE RECOMBINANT AND CHIMERIC VIRUSES: EVALUATION OF RISKS ASSOCIATED WITH CHANGES IN TROPISM Executive summary............................................................................................................................... 5 Introduction............................................................................................................................................ 7 1. Genetic modification of viruses .................................................................................................9 -
Call to Action: the Dangers of Influenza and COVID-19 in Adults
Call to Action The Dangers of Influenza and COVID-19 in Adults with Chronic Health Conditions October 2020 Experts urge all healthcare professionals to prioritize influenza vaccination to help protect adults with chronic health conditions during the COVID-19 pandemic The recommendations in this Call to Action are based on discussions from an Call to Action August 2020 Roundtable convened by the National Foundation for Infectious The Dangers of Influenza Diseases (NFID). The multidisciplinary and COVID-19 in Adults with group of subject matter experts Chronic Health Conditions explored the risks of co-circulation and co-infection with influenza and SARS-CoV-2 viruses in adults with chronic Overview health conditions from the perspective While every influenza (flu) season is unpredictable, of their specialized areas of medicine the 2020-2021 season is characterized by an and discussed strategies to protect unprecedented dual threat: co-circulation of these vulnerable populations. influenza and the novel coronavirus (SARS-CoV-2) that causes COVID-19. Moreover, there is concern Experts agreed that higher levels of that co-circulation and co-infection with influenza influenza vaccination coverage during and COVID-19 viruses could be especially harmful, the 2020-2021 influenza season could particularly among adults at increased risk of reduce the number of influenza-related influenza-related complications. hospitalizations, helping to avoid Influenza poses serious health risks to adults unnecessary strain on the US healthcare with certain chronic health conditions including system during the COVID-19 pandemic, heart disease, lung disease, and diabetes. The so that healthcare facilities have the increased risk of influenza-related complications capacity to provide care to patients includes the potential exacerbation of underlying with COVID-19. -
Technical Glossary
WBVGL 6/28/03 12:00 AM Page 409 Technical Glossary abortive infection: Infection of a cell where there is no net increase in the production of infectious virus. abortive transformation: See transitory (transient or abortive) transformation. acid blob activator: A regulatory protein that acts in trans to alter gene expression and whose activity depends on a region of an amino acid sequence containing acidic or phosphorylated residues. acquired immune deficiency syndrome (AIDS): A disease characterized by loss of cell-mediated and humoral immunity as the result of infection with human immunodeficiency virus (HIV). acute infection: An infection marked by a sudden onset of detectable symptoms usually followed by complete or apparent recovery. adaptive immunity (acquired immunity): See immunity. adjuvant: Something added to a drug to increase the effectiveness of that drug. With respect to the immune system, an adjuvant increases the response of the system to a particular antigen. agnogene: A region of a genome that contains an open reading frame of unknown function; origi- nally used to describe a 67- to 71-amino acid product from the late region of SV40. AIDS: See acquired immune deficiency syndrome. aliquot: One of a number of replicate samples of known size. a-TIF: The alpha trans-inducing factor protein of HSV; a structural (virion) protein that functions as an acid blob transcriptional activator. Its specificity requires interaction with certain host cel- lular proteins (such as Oct1) that bind to immediate-early promoter enhancers. ambisense genome: An RNA genome that contains sequence information in both the positive and negative senses. The S genomic segment of the Arenaviridae and of certain genera of the Bunyaviridae have this characteristic. -
Virus Goes Viral: an Educational Kit for Virology Classes
Souza et al. Virology Journal (2020) 17:13 https://doi.org/10.1186/s12985-020-1291-9 RESEARCH Open Access Virus goes viral: an educational kit for virology classes Gabriel Augusto Pires de Souza1†, Victória Fulgêncio Queiroz1†, Maurício Teixeira Lima1†, Erik Vinicius de Sousa Reis1, Luiz Felipe Leomil Coelho2 and Jônatas Santos Abrahão1* Abstract Background: Viruses are the most numerous entities on Earth and have also been central to many episodes in the history of humankind. As the study of viruses progresses further and further, there are several limitations in transferring this knowledge to undergraduate and high school students. This deficiency is due to the difficulty in designing hands-on lessons that allow students to better absorb content, given limited financial resources and facilities, as well as the difficulty of exploiting viral particles, due to their small dimensions. The development of tools for teaching virology is important to encourage educators to expand on the covered topics and connect them to recent findings. Discoveries, such as giant DNA viruses, have provided an opportunity to explore aspects of viral particles in ways never seen before. Coupling these novel findings with techniques already explored by classical virology, including visualization of cytopathic effects on permissive cells, may represent a new way for teaching virology. This work aimed to develop a slide microscope kit that explores giant virus particles and some aspects of animal virus interaction with cell lines, with the goal of providing an innovative approach to virology teaching. Methods: Slides were produced by staining, with crystal violet, purified giant viruses and BSC-40 and Vero cells infected with viruses of the genera Orthopoxvirus, Flavivirus, and Alphavirus. -
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Review Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines Ekramy E. Sayedahmed 1 , Ahmed Elkashif 1, Marwa Alhashimi 1, Suryaprakash Sambhara 2,* and Suresh K. Mittal 1,* 1 Department of Comparative Pathobiology, Purdue Institute for Immunology, Inflammation and Infectious Disease, Purdue University Center for Cancer Research, College of Veterinary Medicine, Purdue University, West Lafayette, IN 47907, USA; [email protected] (E.E.S.); [email protected] (A.E.); [email protected] (M.A.) 2 Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA * Correspondence: [email protected] (S.S.); [email protected] (S.K.M.) Received: 2 August 2020; Accepted: 17 September 2020; Published: 1 October 2020 Abstract: Ever since the discovery of vaccines, many deadly diseases have been contained worldwide, ultimately culminating in the eradication of smallpox and polio, which represented significant medical achievements in human health. However, this does not account for the threat influenza poses on public health. The currently licensed seasonal influenza vaccines primarily confer excellent strain-specific protection. In addition to the seasonal influenza viruses, the emergence and spread of avian influenza pandemic viruses such as H5N1, H7N9, H7N7, and H9N2 to humans have highlighted the urgent need to adopt a new global preparedness for an influenza pandemic. It is vital to explore new strategies for the development of effective vaccines for pandemic and seasonal influenza viruses. The new vaccine approaches should provide durable and broad protection with the capability of large-scale vaccine production within a short time. The adenoviral (Ad) vector-based vaccine platform offers a robust egg-independent production system for manufacturing large numbers of influenza vaccines inexpensively in a short timeframe. -
Bronchiolitis
Bronchiolitis What is bronchiolitis? Bronchiolitis is a viral infection of the lungs that usually affects infants. There is swelling in the smaller airways or bronchioles of the lung, which causes coughing and wheezing. Bronchiolitis is the most common reason for children under 1 year old to be admitted to the hospital. What are the symptoms of bronchiolitis? The following are the most common symptoms of bronchiolitis. However, each child may experience symptoms differently. Symptoms may include: Runny nose or nasal congestion Fever Cough Changes in breathing patterns (wheezing and breathing faster or harder are common) Decreased appetite Fussiness Vomiting What causes bronchiolitis? Bronchiolitis is a common illness caused by different viruses. The most common virus causing this infection is Respiratory Syncytial Virus (RSV). However, many other viruses can cause bronchiolitis including: Influenza, Parainfluenza, Rhinovirus, Adenovirus, and Human metapneumovirus. Initially, the virus causes an infection in the upper airways, and then spreads downward into the lower airways of the lungs. The virus causes swelling of the airways. Mucus is also produced in the airways. This narrowing of the airways can make it difficult for your child to breath, eat, or nurse. How is bronchiolitis diagnosed? Bronchiolitis is usually diagnosed on the history and physical examination of the child. Antibiotics are not helpful in treating viruses and are not needed to treat bronchiolitis. Because there is no cure for the disease, the goal of treatment is to make your child comfortable and to support their symptoms. This treatment may include suctioning to keep the airways clear, extra oxygen if the blood oxygen levels are low, or hydration if your child is not able to feed well.